Results for 'oncology clinical trial'
Monty Pal
Breaking Barriers in Cancer Care: Expanding Access, Innovation & Integrative Medicine
City of Hope, Monty Pal, Edward Kim, integrative oncology, national clinical trial, patient access
Dr. Ed Kim shares insights on why redefining the standard of care is critical for improving patient outcomes, the future of clinical trials, and the role of integrative medicine in oncology.
Mar 21st • 33 mins listen
Monty Pal
Three Leaders, One Vision: Principles for Transforming Cancer Care Delivery
City of Hope, Monty Pal, Walter Stadler, Alan Bryce, ASCO, national model, precision, AI, clinical trial design, dose strategy, early detection, long term survivorship
Dr. Walter Stadler & Dr. Alan Bryce share how City of Hope is building a national system for smarter research, greater access, and better cancer care.
Jun 23rd • 43 mins listen
Rebecca Previs
Tumor-Agnostic Therapies and the Future of HER2 in Oncology
Labcorp, Rebecca Previs, Heidi Ko, HER2, NGS, precision oncology, tumor agnostic, breast cancer, gastric cancer, biomarker, ERBB2, IHC, FISH, biomarker
What tumor-agnostic approvals mean for HER2, NGS, and precision oncology — and how they’re changing treatment across cancer types.
Jun 8th • 20 mins listen
Kirk Shepard
How Cross-Functional Teams Reshape Cancer Care
Jay Fine, Preclinical Research, Early Stage
In episode 3 of Oncology Voice Network Podcast, Dr. Kirk Shepard sits down with Dr. Jay Fine, a renowned immunologist and President of R&D at Evolve Immune Therapeutics and a Forbes-published author in Voices of Oncology, for a candid look at how discovery truly connects to patient care.
Feb 17th • 23 mins listen
Kirk Shepard
Breakthroughs in Oncology Drug Development with Dr. Roy Baynes
How do world-changing cancer treatments go from concept to reality? Tune in and discover how strategy, leadership, and heart unite to change lives in oncology—listen now.
Mar 31st • 28 mins listen
Cancer Buzz Podcast
IO Clinical Trials During COVID-19
On this episode of CANCER BUZZ, we look at how immunotherapy clinical trials have been affected by the pandemic and what cancer programs can do to safely and effectively administer clinical trials. Guest: Joanne Riemer, RN, BSN, Research Oncology Nurse, Sidney Kimmel Comprehensive …
Jun 23rd • 13 mins listen
Cancer Buzz Podcast
Advancing Clinical Trial Equity
Increasing diversity and equity in clinical trials will require buy-in and commitment from all stakeholders in the research enterprise. In this episode, Colleen Lewis, MSN, ANP-BC, AOCNP, talks about the critical role oncology advanced practitioners can play in moving the needle on equity and incl…
Jun 25th • 8 mins listen
Journal of Clinical Oncology (JCO) Podcast
Lack of Gender Equity in Oncology Clinical Trial Advisory Board Membership
Shannon Westin, Pamela Kunz, and Rachna Shroff discuss the lack of gender equity on oncology industry advisory boards.
Nov 25th • 23 mins listen
Journal of Clinical Oncology (JCO) Podcast
Barriers to Clinical Trial Participation for Transgender People
What factors could be excluding transgender people from oncology clinical trials, and what can we do to make them more inclusive? Dr. Westin discusses this important issue with her guests, Dr. Ash Alpert and Dr. Lola Fashoyin-Aje.
Apr 25th • 26 mins listen
Asco Daily News Podcast
How AI Can Improve Patient Identification and Recruitment for Clinical Trials
On today's episode, we will be discussing the promise of artificial intelligence to improve patient recruitment in clinical trials and advanced clinical research. Joining me for this discussion is Dr. Arturo Loaiza-Bonilla, the medical director of oncology research at Capital Health in Philad…
Aug 15th • 19 mins listen
The Oncology Nursing Podcast
The Practical Side of Clinical Trials
ONS member Teresa Knoop, MSN, RN, AOCN®, assistant director of clinical trials at Vanderbilt Ingram Cancer Center in Nashville, TN, joins ONS’s Barbara Lubejko, MS, RN, to discuss the practical side of clinical trials for oncology nursing, including addressing long-term side effects, han…
Sep 18th • 39 mins listen
The Oncology Nursing Podcast
Oncology Clinical Trials and Drug Development
ONS member Moe Schwartz, PharmD, BCOP, professor of pharmacy practice in the James L. Winkle College of Pharmacy at the University of Cincinnati in Ohio and member of the Cincinnati Tri-State ONS Chapter, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss cancer drug…
Oct 16th • 38 mins listen
The Oncology Nursing Podcast
Diversity in Cancer Clinical Trials
“I think it’s important to ensure that you consider each person uniquely. Because no matter how much I know or the nurse knows about the population, everybody is a little bit different. It’s really important to personalize every approach and ask them what they know and meet them …
May 29th • 27 mins listen
The Oncology Nursing Podcast
Oncology Pharmacology 2023: Today’s Treatments and Tomorrow’s Breakthroughs
CDER, FDA, Nurses, biomarker, immunomodulatory
Highlights From Today’s Episode “Full approval through the Center for Drug Evaluation and Research (CDER) and FDA means that those drugs have gone through the laboratory testing, human clinical trial testing, and very extensive clinical trials to make sure that they are effective and th…
Mar 30th • 53 mins listen
Rebecca Previs
Empowering Breast Cancer Patients: Biomarker Breakthroughs & Self-Advocacy
Rebecca Previs, Suzanne Garner, breast cancer, digital, biomarker, genetic testing, advocacy
Suzanne Garner’s journey shows how education, advocacy, and technology are reshaping breast cancer patient care and clinical trial access.
Oct 19th • 26 mins listen
Rebecca Previs
ctDNA Breakthroughs in Mesothelioma Care
Labcorp, Rebecca Previs, Mark Sausen, immunotherapy, mesothelioma, checkpoint blockade, ctDNA, imaging
Exploring immunotherapy and ctDNA innovation in mesothelioma, where molecular monitoring may redefine early cancer detection and treatment.
Nov 3rd • 15 mins listen
Rebecca Previs
FFPE: The Workhorse Behind NGS Testing
Labcorp, Rebecca Previs, Kyle Strickland, Erin Newburn, biomarker, sequencing, diagnostics, translational research, precision
Exploring FFPE’s impact on precision oncology, NGS innovation, and the future of tissue stewardship in cancer care with leading Labcorp experts.
Jan 28th • 33 mins listen
Michael Pietrack
Aspiring MSL Insight: Do You Have a Back-Pocket Presentation?
If you’re an aspiring MSL, you’re probably thinking a lot about how to master the MSL interview. 🎤 The biggest part of the interview is the presentation you’ll give during the final interview. 📊 One way to really shine on this very important element of the evaluation process …
Jul 22nd • 3 mins listen
Cancer Buzz Podcast
Advanced Practitioners’ Role in Research
In this episode, we'll explore how oncology advanced practitioners (APs) can play a greater role in clinical research and, according to a recent national study, have a strong interest in doing so. Hear how APs can leverage their deep role in the day-to-day cancer care decisions to improve diversit…
Jul 13th • 6 mins listen
The Oncology Nursing Podcast
Patient Education for Next-Generation Sequencing to Guide Cancer Therapy
Highlights From Today’s Episode “With next-generation sequencing (NGS), multiple biomarkers can be evaluated using one test. So, in cancer care, we’re learning that any given tumor may harbor a variety of variants. So, if we’re considering using in situ hybridization (ISH)…
Mar 30th • 47 mins listen